The Bloom 167 - Neuroplasticity November


The Bloom #167

Free Edition

hyper-psychoplastogens

What is the effect of psychedelics inside our brains?

A comprehensive review argues that psychedelics lead to hyper-plasticity (re-opening developmental windows) and meta-plasticity (sensitivity to stimuli). However, a meta-analysis argues that BNDF - in humans - only minimally changed in human studies (vs animal studies). Still, the first review (see below) points to many other mechanisms that may underly the long-term psychological effects of psychedelics.

A lot of the psychedelic clinical research is done with participants who have never done psychedelics, or only a handful of times. A very different observational study looks at participants who've done over 500 ayahuasca ceremonies (on average) and finds enhancement in memory (whilst not impacting false memories).

These studies, and 16 more can be found in the November psychedelic research recap.

Floris - Founder of Blossom

ps Next week (Dec 11th), we're diving into psychedelics and design. Check out the virtual conference here.

pps Later today, a study on psilocybin therapy for clinicians with symptoms of depression from frontline care during the COVID-19 pandemic will be published and can be found in the papers database

Latest Psychedelic Research

1 Neuroplasticity and Psychedelics: a comprehensive examination of classic and non-classic compounds in pre and clinical models

This pre-print review (2024) examines the effects of classic psychedelics (e.g., LSD, psilocybin, DMT) and non-classic psychedelics (e.g., ketamine, MDMA) on neuroplasticity. Drawing on preclinical and clinical studies, it discusses molecular, structural, and functional changes induced by these agents, highlighting their potential to re-open developmental windows (hyper-plasticity) and increase nervous system sensitivity to stimuli (meta-plasticity). Translating findings to humans remains challenging, but emerging tools like PET radioligands and multimodal approaches offer promise for future research.

Unlock 2150+ Psychedelic Research Summaries with a Pro Membership

Discover a treasure trove of knowledge and support the vital coverage & advancement of psychedelic research

2 Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis

This meta-analysis (s=29) examines the effects of psychedelics (including ketamine and MDMA) and two other 'psychoplastogens' on peripheral BDNF levels in humans. It finds no significant changes in BDNF levels post-administration (SMD=0.024, p=0.64), regardless of drug, dose, participant age, or psychiatric condition. Studies with better-controlled designs report smaller effect sizes, and later timepoints show minimal increases in BDNF. The authors conclude that peripheral BDNF is likely not a reliable marker of rapid neuroplasticity and recommend neuroimaging or stimulation-based methods for future research.

3 Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study

This observational study (n=24) examines the acute effects of ayahuasca on memory in experienced Santo Daime members (>500 lifetime uses). Findings show ayahuasca enhances memory accuracy and recollection while not impacting familiarity or false memory, suggesting β-carboline activity may drive selective improvements in hippocampal-dependent processes.

More Research

New on Blossom

1 Psychedelic Research Recap November 2024

In November, psychedelic research spans from clinical applications to fundamental neuroscience. Studies provide new insights into how psilocybin, MDMA, and ketamine can affect mental health conditions such as depression, PTSD, OCD, and fibromyalgia. Researchers are also examining the safety profiles of substances like mescaline and 3-MMC.

Several studies examine the mechanisms behind psychedelics’ therapeutic effects, focusing on neuroplasticity and neuronal pathways. From exploring how psychedelics (don’t) influence brain-derived neurotrophic factor (BDNF) levels to understanding their impact on specific pyramidal cells in the cortex, these findings shed light on how these substances may promote lasting psychological benefits.

The research this month places special emphasis on user experiences during psychedelic sessions and how they relate to therapeutic outcomes. Studies investigate major life changes following psychedelic use, strategies for navigating challenging experiences, and the effects of psychedelics on memory and self-related thought processes.

We also see important findings regarding safety and adverse effects, including reevaluations of the incidence of psychedelic-induced psychosis and new insights into MDMA-induced hyponatremia. Additionally, a cost-effectiveness analysis of MDMA-assisted therapy for PTSD suggests promising economic viability for these treatments.

Achieve Transformative Growth with FLO Coaching

"I would recommend this to anyone who wants to look deeper into themselves in a safe environment" - Izak

1-on-1 psilocybin-assisted coaching in Dutch legal framework offered by yours truly and my wife Lotte

2 Psychedelics and Creativity

Written in collaboration with Dilara Oexemann.

  • Psychedelics may increase creative thinking by disrupting the Default Mode Network (DMN), enhancing cognitive flexibility and openness to new ideas.
  • Flexible, divergent thinking, fostered by psychedelics, can help treat mental health disorders such as anxiety and depression, according to research on these substances’ potential therapeutic effects.
  • More research is needed to understand the long-term effects of psychedelics on creativity, with implications for both therapeutic and recreational uses.

3 Psychedelic Research Links 2024

All the other papers that have come out this year that don't have a separate entry in the database.

Spotlight

1 Psychedelics Design Conference (Event)

My good friend Alex—a brilliant designer—and your humble psychedelic research enthusiast have put together an exiting event: the Psychedelics Design Online Conference on December 11, 2024. This unique gathering will explore the intersection of art, science, design, and engineering, shedding light on the transformative potential of psychedelics.

We aim to connect like-minded individuals, share groundbreaking insights, and build a collaborative community that benefits society and the planet.

Join us to engage with renowned speakers and immerse yourself in innovative discussions that promise to inspire and provoke thought. Don’t miss this opportunity to be part of a movement at the forefront of psychedelic exploration and design.

Use code BLOSSOM15 for a 15% discount.

Molenvaart 76, Anna Paulowna, NH 1761AL
Unsubscribe · Preferences

Floris from Blossom

I write about the science and implementation of psychedelics as medicines. Join to learn alongside me and make the future happen sooner!

Read more from Floris from Blossom

The Bloom #174 Free Edition vive la Europe Today I'm launching something I'm incredibly proud of—a comprehensive report on psychedelic therapy reimbursement in Europe. While psychedelic therapies show enormous potential for conditions like depression, PTSD, and addiction, securing reimbursement remains a critical challenge. The 200-page analysis maps out the hurdles and offers clear strategies to ensure these life-changing treatments can reach patients who urgently need them. Dive into the...

The Bloom #173 Free Edition long-term follow-up The psychedelic research landscape continues to evolve at a remarkable pace. Last month, I tracked 193 new studies and added the 11 most significant ones to our database. In this monthly recap, I've synthesized what we've learned from these latest findings. Two standout studies examine the long-term outcomes from both clinical trials and observational research. The durability of psychedelic effects represents a critical area of investigation—one...

The Bloom #172 Free Edition what do you think? What happens during a psychedelic trip? How can we minimise harms? Do psychedelics reduce feelings of shame? Why do people trip? Do researchers get funding for psychedelic research? Are social workers open to psychedelic therapy? These are but some of the questions that 14 surveys (about one a day) have asked in published research this month. We cover the first three in the research papers below. In other new research, we look at a new...